Among Patients With Myeloma Undergoing Chemo, High Exercise Compliance Linked With Reduced Fatigue
the ONA take:
Among patients with multiple myeloma, high compliance with exercise was associated with improvements in fatigue, according to a study published in the October 2015 issue of the journal Supportive Care in Cancer.
Because exercise is considered beneficial and safe in patients with multiple myeloma, which is commonly associated with osteolytic bone disease and anemia, resulting in skeletal fragility, persistent fatigue, pain, and reduced quality of life, researchers at the Jewish General Hospital in Montreal, Canada, sought to evaluate the extent of exercise compliance in this patient population.
For the retrospective study, researchers analyzed data from 41 patients with multiple myeloma who participated in a hospital-based rehabilitation program while undergoing chemotherapy. Results showed that exercise compliance was 71% at follow-up and was associated with a decrease in fatigue severity scores.
Researchers found that participants with a history of pathological fracture, spinal cord compression, or radiation were at an increased risk for noncompliance and may therefore require additional supervision to improve exercise compliance.
Among patients with multiple myeloma, high compliance with exercise was associated with improvements in fatigue.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|